Alligator Bioscience AB (publ) reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was SEK 17.36 million compared to SEK 5.17 million a year ago. Revenue was SEK 18.67 million compared to SEK 5.44 million a year ago. Net loss was SEK 63.71 million compared to SEK 45.71 million a year ago. Basic loss per share from continuing operations was SEK 0.19 compared to SEK 0.21 a year ago. Diluted loss per share from continuing operations was SEK 0.19 compared to SEK 0.21 a year ago.
For the six months, sales was SEK 26.96 million compared to SEK 10.53 million a year ago. Revenue was SEK 29.09 million compared to SEK 10.99 million a year ago. Net loss was SEK 126.26 million compared to SEK 88.79 million a year ago. Basic loss per share from continuing operations was SEK 0.46 compared to SEK 0.4 a year ago. Diluted loss per share from continuing operations was SEK 0.46 compared to SEK 0.4 a year ago.